Doheny Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,000	Closed	-$59K	–	96
2019 Q2	$59K	Hold	22,000	–	–	0.05%	91
2019 Q1	$65K	Hold	22,000	–	–	0.06%	94
2018 Q4	$35K	Hold	22,000	–	–	0.03%	89
2018 Q3	$81K	Hold	22,000	–	–	0.04%	100
2018 Q2	$62K	Sell	22,000 -17,000	-44%	-$47.9K	0.03%	100
2018 Q1	$145K	Hold	39,000	–	–	0.08%	102
2017 Q4	$112K	Hold	39,000	–	–	0.05%	106
2017 Q3	$175K	Hold	39,000	–	–	0.08%	107
2017 Q2	$179K	Sell	39,000 -1,000	-3%	-$4.59K	0.08%	105
2017 Q1	$168K	Hold	40,000	–	–	0.08%	112
2016 Q4	$165K	Sell	40,000 -44,850	-53%	-$185K	0.08%	106
2016 Q3	$687K	Sell	84,850 -21,000	-20%	-$170K	0.35%	64
2016 Q2	$826K	Sell	105,850 -5,800	-5%	-$45.3K	0.41%	56
2016 Q1	$862K	Sell	111,650 -348,900	-76%	-$2.69M	0.44%	55
2015 Q4	$4.97M	Sell	460,550 -49,575	-10%	-$535K	2.43%	10
2015 Q3	$3.53M	Sell	510,125 -42,875	-8%	-$296K	1.83%	19
2015 Q2	$4.9M	Buy	553,000 +51,050	+10%	+$452K	2.19%	13
2015 Q1	$4.95M	Sell	501,950 -15,500	-3%	-$153K	2.29%	12
2014 Q4	$6.34M	Sell	517,450 -24,875	-5%	-$305K	3.03%	7
2014 Q3	$5.41M	Sell	542,325 -183,900	-25%	-$1.84M	2.71%	9
2014 Q2	$5.5M	Sell	726,225 -396,100	-35%	-$3M	2.6%	9
2014 Q1	$3.69M	Buy	1,122,325 +144,300	+15%	+$475K	1.9%	16
2013 Q4	$3.25M	Buy	978,025 +910,375	+1,346%	+$3.02M	1.71%	21
2013 Q3	$204K	Buy	67,650 +20,645	+44%	+$62.3K	0.11%	92
2013 Q2	$385K	Buy	+47,005	New	+$385K	0.22%	83